5068202026-08-055068202026-08-05ActionsTakenOrOrdersPassedDomain15068202026-08-05ActionsTakenOrOrdersPassedDomain1PersonsAgainstWhomActionsTakenOrOrdersPassedDomain15068202026-08-05SignatoriesDomain1xbrli:pureASTRAZENASTRAZENECA PHARMA INDIA LIMITED506820NOTLISTEDINE203A01020NewAction(s) taken or orders passed (sub-para 20)false2026-07-2921:00:002026-08-05Any other similar action(s)Demand NoticeRegulatory AuthorityNational Pharmaceutical Pricing Authority1Listed Entity (Self)ASTRAZENECA PHARMA INDIA LIMITEDDemand NoticeDemand Notice issued by the NPPA for alleged overcharging under the Drugs (Prices Control) Order, 2013 (‘DPCO, 2013’) of Rs. 1,48,65,83,590/- inclusive of interest calculated upto August 20, 2026.2026-07-29Further to a show cause notice dated September 11, 2025, the Company has received a demand notice from NPPA on July 29, 2026, in relation to Symbicort Turbuhaler 160/4.5 (Inhaler). NPPA has alleged overcharging for the period from May 2016 to November 2025 under DPCO, 2013 and has demanded Rs. 1,48,65,83,590/-, including interest, payable within 30 days from receipt of the notice. The Company is currently evaluating the demand notice and appropriate legal actions.As referred aboveRs. 1,48,65,83,590/- inclusive of interest calculated upto August 20, 2026.As referred aboveNot applicableAs referred aboveThe Company is currently evaluating the demand notice and appropriate legal actions.NoneTanya SanishCompany Secretary & Compliance Officer2026-08-05Mumbai